The EPS projection of Proofpoint, Inc. (NASDAQ:PFPT) for quarter ended 2016-09-30 is $-0.57. Last week, the EPS forecast was $-0.57 against target of $-0.57, a month earlier. Two months ago, this estimate was $-0.57 versus forecast of $-0.57 three months earlier, implying a deviation of 0%.
Proofpoint, Inc. (NASDAQ:PFPT) stated that 18 days ago, its stock price was positively revised 1 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 2, 0, and 2, correspondingly.
EPS estimate downgrade for Proofpoint, Inc. (NASDAQ:PFPT) in the preceding 30, 120, 60 and 90 days were 0, 0, 0, and 0, correspondingly.
Proofpoint, Inc. (NASDAQ:PFPT) EPS target for the quarter closed 1 was $-0.57, based on 2 recommendations. As reported on 2016-04-21 the EPS was $-0.54. The change was $0.06, implying a percentage deviation of 10%. The projections showed a standard deviation of 0.03.
Quarterly Sales Estimates
Proofpoint, Inc. (NASDAQ:PFPT) yearly sales prediction for the fiscal 2017 stands at $126.115 and the median estimate is at $127. Almost 4 analysts issued sales target.
Highest sales target is $131 while the lowest target is $119.46 showing standard deviation of 4.876%.
As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.
Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of 0.598%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast. Proofpoint, Inc. (NASDAQ:PFPT) announced that the deviation in forecast was 0.661%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...